Strengthens the Novartis oncology pipeline with two lead ADC assets and a broader payload platform with potential impact ...
Basel, July 2, 2026 – Novartis today announced that the European Commission (EC) has approved Itvisma ® (onasemnogene ...
Late-breaking positive Phase III data from ianalumab NEPTUNUS-1 and NEPTUNUS-2 trials in Sjögren’s disease to be presented ; Biomarker data informing use of investigational CAR ...
Our work is powered by a toolkit of five R&D approaches – two established platforms (chemistry and biotherapeutics) plus three advanced platforms (xRNA, radioligand therapy and gene and cell therapy) ...
Imagine performing research at a leading global pharmaceutical corporation while gaining practical experience and contributing to the search for new disease therapies. Through internship programs at ...
You can break new ground in how we bring treatments to patients when you join us in Sales. Collaborating closely with Marketing, Access and Medical teams, you’ll educate healthcare professionals about ...
Brochure "Explanations of the Board of Directors on the Amendment of the Articles of Incorporation" English (PDF 0.1 MB) Deutsch (PDF 0.2 MB) Français (PDF 0.1 MB) Statement regarding Agenda Item 6.1 ...
Transforming the treatment and healthcare system landscape using early interventions, pioneering treatments, and innovative partnerships to avoid preventable mortality from cardiovascular disease (CVD ...
Disclaimer: The information provided on this website does not constitute investment advice, or an offer of, or an invitation or solicitation by, or on behalf of, Novartis AG or any of its subsidiaries ...
Awareness and training programs are offered regularly in a range of formats, including awareness-building programs, e-training, face-to-face programs, games and workshops. We provide extensive ...
Novartis uses the open-source Drupal content management framework for many key websites, including our flagship global site Novartis.com, main country sites, portals for healthcare professionals, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results